Kimberly Manhard, Executive VP, Drug Development at HERON THERAPEUTICS, INC. /DE/ (HRTX), sold 6,000 shares at $37.51 ($225K) on 2018-07-02, disclosed to the SEC on 2018-07-03.
Open-market sale of $225k HRTX by Executive VP, Drug Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.51 | 5,900 | $221K | 98.3% |
| 2 | $38.85 | 100 | $4K | 1.7% |
| Total | $37.53 avg | 6,000 | $225K | 100% |
| Filing → |
| INBX | BUY | 2024-08-30 | $140K | — | Filing → |
| HRTX | SELL | 2022-05-04 | $7K | — | Filing → |
| HRTX | SELL | 2021-05-04 | $27K | — | Filing → |